$2.88
00.00%
Pre-Market: Jul 19, 4:02 PM EDT
15 minutes delayed
Comments
Loading...
Generation Bio
GBIONASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Generation Bio (NASDAQ:GBIO) Stock, Analyst Ratings, Price Targets, Forecasts
Generation Bio Co has a consensus price target of $8.25 based on the ratings of 6 analysts. The high is $10 issued by Needham on May 14, 2024. The low is $5 issued by Wedbush on May 14, 2024. The 3 most-recent analyst ratings were released by Needham, Wedbush, and Needham on May 14, 2024, May 14, 2024, and April 10, 2024, respectively. With an average price target of $8.33 between Needham, Wedbush, and Needham, there's an implied 189.35% upside for Generation Bio Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Wedbush
JP Morgan
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Generation Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 247.22% | Needham | Gil Blum | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 73.61% | Wedbush | David Nierengarten | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 04/10/2024 | Buy Now | 247.22% | Needham | Gil Blum | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 73.61% | Wedbush | David Nierengarten | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | Buy Now | 247.22% | Needham | Gil Blum | $14 → $10 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | 212.5% | Wedbush | David Nierengarten | $11 → $9 | Maintains | Outperform | Get Alert |
| 10/23/2023 | Buy Now | — | JMP Securities | Silvan Tuerkcan | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/19/2023 | Buy Now | — | TD Cowen | Yaron Werber | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/16/2023 | Buy Now | 212.5% | JP Morgan | Anupam Rama | $8 → $9 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 386.11% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 08/03/2023 | Buy Now | 281.94% | Wedbush | David Nierengarten | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 386.11% | Needham | Gil Blum | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2023 | Buy Now | 386.11% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | Buy Now | 143.06% | JMP Securities | Silvan Tuerkcan | → $7 | Reiterates | → Market Outperform | Get Alert |
| 03/23/2023 | Buy Now | 386.11% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | Buy Now | -22.57% | JMP Securities | Silvan Tuerkcan | $7 → $2.23 | Maintains | Market Outperform | Get Alert |
| 02/24/2023 | Buy Now | 420.83% | Wedbush | David Nierengarten | $24 → $15 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 386.11% | Needham | Gil Blum | $23 → $14 | Maintains | Buy | Get Alert |
| 01/19/2023 | Buy Now | 143.06% | JMP Securities | Silvan Tuerkcan | $11 → $7 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | Buy Now | 212.5% | Canaccord Genuity | Whitney Ijem | → $9 | Initiates | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 281.94% | JMP Securities | Silvan Tuerkcan | $10 → $11 | Maintains | Market Outperform | Get Alert |
| 08/05/2022 | Buy Now | 698.61% | Needham | Gil Blum | $27 → $23 | Maintains | Buy | Get Alert |
| 12/15/2021 | Buy Now | 247.22% | JMP Securities | Silvan Tuerkcan | — | Maintains | Market Outperform | Get Alert |
| 12/15/2021 | Buy Now | 837.5% | Needham | Gil Blum | — | Maintains | Buy | Get Alert |
| 12/14/2021 | Buy Now | 976.39% | Wedbush | David Nierengarten | $36 → $31 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Generation Bio (GBIO) stock?
The latest price target for Generation Bio (NASDAQ:GBIO) was reported by Needham on May 14, 2024. The analyst firm set a price target for $10.00 expecting GBIO to rise to within 12 months (a possible 247.22% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Generation Bio (GBIO)?
The latest analyst rating for Generation Bio (NASDAQ:GBIO) was provided by Needham, and Generation Bio reiterated their buy rating.
When was the last upgrade for Generation Bio (GBIO)?
There is no last upgrade for Generation Bio
When was the last downgrade for Generation Bio (GBIO)?
The last downgrade for Generation Bio Co happened on October 23, 2023 when JMP Securities changed their price target from N/A to N/A for Generation Bio Co.
When is the next analyst rating going to be posted or updated for Generation Bio (GBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Generation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Generation Bio was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Generation Bio (GBIO) correct?
While ratings are subjective and will change, the latest Generation Bio (GBIO) rating was a reiterated with a price target of $10.00 to $10.00. The current price Generation Bio (GBIO) is trading at is $2.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.